Katherine Henthorne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katherine Henthorne has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Janice Wang
Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, NY 11042, USA
3 shared publications - Melissa Basile
Northwell Health, New Hyde Park, United States
3 shared publications - Christine Esposito
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, United States
2 shared publications - Aileen Espinal
Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY 11042, United States
1 shared publication - Alison Huenger
Northwell Health, New Hyde Park, United States
1 shared publication - Alison T. Lennox
Division of Pediatric Pulmonology, Allergy, Immunology, and Sleep Medicine, New York Medical College, Valhalla, NY 10595, United States
1 shared publication
Latest Publications
- 2 July 2025
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 33 (3) , 367-382
The Impact of Personal-Level Social Networks on Treatment Adherence, Depression, Anxiety, and Perceived Stigma Among Adults with Cystic Fibrosis: An Egocentric Network Analysis
Background Among people with cystic fibrosis (CF), health behaviors and mental health have been associated with general social support. We used egocentric network analysis to assess the specific impact of social network variables on treatment adherence, depression, anxiety, and perceived stigma among adults with CF. Our goal is to identify the social network factors which may be driving adherence, anxiety, depression, and perceived stigma among adults with CF toward developing targeted network-based interventions. Method Our primary outcome, adherence to individual-level treatment regimens, was assessed using composite prescription refill history (cMPR), self-reported airway clearance therapy (ACT), and consumption of all prescriptions. Secondary outcomes were assessed via patient completion of the Patient Health Questionnaire-9 (PHQ-9) for depression, the General Anxiety Disorder-7 (GAD-7) for anxiety, and the CF Stigma Scale for perceived stigma. Participants also completed a social network interview to collect data on personal-level networks. Controlling for participant age, sex, race, relationship status, work status, and CF disease severity, we explored the impact of network variables on our primary and secondary outcomes using regression analysis. All models were run twice to assess both core and strong network ties. Results Regression analysis of 104 participants showed that strong network ties serving as health discussants and health regulators were positively associated with stronger adherence, while financial dependence and network density were associated with decreased adherence. Network alters having higher education levels, strong trust in doctors, and support for daily activities were associated with lower depression, anxiety, and perceived stigma. Participants having a higher proportion of network members who hassled them and had lower trust and/or greater variability in trust in doctors experienced higher depression, anxiety, and perceived stigma. Conclusion Findings show that network-based variables including close ties to health discussants, network members’ education levels, and health beliefs, as well as having network members providing support for daily activities may be driving specific aspects of adherence, symptoms of depression and anxiety, and perceived stigma among adults with CF. These findings may thus allow us to leverage social networks in the development of novel interventions to improve adherence and mental health and reduce perceived stigma for people with CF.
- 2 July 2025
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 33 (3) , 367-382
The Impact of Personal-Level Social Networks on Treatment Adherence, Depression, Anxiety, and Perceived Stigma Among Adults with Cystic Fibrosis: An Egocentric Network Analysis
Background Among people with cystic fibrosis (CF), health behaviors and mental health have been associated with general social support. We used egocentric network analysis to assess the specific impact of social network variables on treatment adherence, depression, anxiety, and perceived stigma among adults with CF. Our goal is to identify the social network factors which may be driving adherence, anxiety, depression, and perceived stigma among adults with CF toward developing targeted network-based interventions. Method Our primary outcome, adherence to individual-level treatment regimens, was assessed using composite prescription refill history (cMPR), self-reported airway clearance therapy (ACT), and consumption of all prescriptions. Secondary outcomes were assessed via patient completion of the Patient Health Questionnaire-9 (PHQ-9) for depression, the General Anxiety Disorder-7 (GAD-7) for anxiety, and the CF Stigma Scale for perceived stigma. Participants also completed a social network interview to collect data on personal-level networks. Controlling for participant age, sex, race, relationship status, work status, and CF disease severity, we explored the impact of network variables on our primary and secondary outcomes using regression analysis. All models were run twice to assess both core and strong network ties. Results Regression analysis of 104 participants showed that strong network ties serving as health discussants and health regulators were positively associated with stronger adherence, while financial dependence and network density were associated with decreased adherence. Network alters having higher education levels, strong trust in doctors, and support for daily activities were associated with lower depression, anxiety, and perceived stigma. Participants having a higher proportion of network members who hassled them and had lower trust and/or greater variability in trust in doctors experienced higher depression, anxiety, and perceived stigma. Conclusion Findings show that network-based variables including close ties to health discussants, network members’ education levels, and health beliefs, as well as having network members providing support for daily activities may be driving specific aspects of adherence, symptoms of depression and anxiety, and perceived stigma among adults with CF. These findings may thus allow us to leverage social networks in the development of novel interventions to improve adherence and mental health and reduce perceived stigma for people with CF.
- Open Access
Addressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature
Among people with cystic fibrosis (CF), illness burden is multifaceted, and symptoms may fluctuate in intensity across a lifespan. Caregivers of people with CF may also experience distressing symptoms. Recent developments in CF care, including the availability of highly effective modulator therapies (HEMTs) and new palliative care guidelines promoting palliative care screening may help alleviate symptoms. The objective of this review was to present a narrative view of the recent literature on symptom burden in CF, new screening approaches informed by the Cystic Fibrosis Foundation (CFF) palliative care guidelines, and early data from studies examining the impact of HEMTs on CF symptom burden. A review of the relevant literature was conducted using Google Scholar and PubMed. Included articles covered approaches to burden assessment in CF and other chronic illnesses, epidemiology of CF symptom burden, the impact of HEMTs on symptom burden, and the CFF palliative care guidelines. A primary palliative care model implementing the CFF guidelines was also described. Results of this review show that while recent developments in CF care have led to a reduction in physical symptoms, mental health symptoms remain prevalent. Ongoing screening and triage can ensure that physical symptoms, psychological symptoms, social needs, practical problems, and communication concerns are addressed by care teams.
Open AccessAddressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature
Among people with cystic fibrosis (CF), illness burden is multifaceted, and symptoms may fluctuate in intensity across a lifespan. Caregivers of people with CF may also experience distressing symptoms. Recent developments in CF care, including the availability of highly effective modulator therapies (HEMTs) and new palliative care guidelines promoting palliative care screening may help alleviate symptoms. The objective of this review was to present a narrative view of the recent literature on symptom burden in CF, new screening approaches informed by the Cystic Fibrosis Foundation (CFF) palliative care guidelines, and early data from studies examining the impact of HEMTs on CF symptom burden. A review of the relevant literature was conducted using Google Scholar and PubMed. Included articles covered approaches to burden assessment in CF and other chronic illnesses, epidemiology of CF symptom burden, the impact of HEMTs on symptom burden, and the CFF palliative care guidelines. A primary palliative care model implementing the CFF guidelines was also described. Results of this review show that while recent developments in CF care have led to a reduction in physical symptoms, mental health symptoms remain prevalent. Ongoing screening and triage can ensure that physical symptoms, psychological symptoms, social needs, practical problems, and communication concerns are addressed by care teams.
- 21 February 2022
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 21 (3) , e176-e183
The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York
- 21 February 2022
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 21 (3) , e176-e183
The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York
- 1 November 2019
- Published by Elsevier in Patient Education and Counseling
- Vol. 102 (11) , 1985-1990
Using qualitative methods to inform the design of a decision aid for people with advanced cystic fibrosis: The InformedChoices CF patient decision aid
- 1 November 2019
- Published by Elsevier in Patient Education and Counseling
- Vol. 102 (11) , 1985-1990
Using qualitative methods to inform the design of a decision aid for people with advanced cystic fibrosis: The InformedChoices CF patient decision aid